In vivo immunohistochemistry (IHC) experimental data showed that vernodalin can induce tumor growth by inducing the expression of FOXO3a and p27Kip1 (Ananda Sadagopan et al., 2015). The gene discussed is CDKN1B; the disease is neoplasm.